Annual D&A
$61.90 M
+$9.20 M+17.46%
December 1, 2023
Summary
- As of February 7, 2025, MYGN annual depreciation & amortization is $61.90 million, with the most recent change of +$9.20 million (+17.46%) on December 1, 2023.
- During the last 3 years, MYGN annual D&A has risen by +$26.10 million (+72.91%).
- MYGN annual D&A is now -15.21% below its all-time high of $73.00 million, reached on June 30, 2019.
Performance
MYGN Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$15.60 M
+$500.00 K+3.31%
September 1, 2024
Summary
- As of February 7, 2025, MYGN quarterly depreciation & amortization is $15.60 million, with the most recent change of +$500.00 thousand (+3.31%) on September 1, 2024.
- Over the past year, MYGN quarterly D&A has dropped by -$100.00 thousand (-0.64%).
- MYGN quarterly D&A is now -19.59% below its all-time high of $19.40 million, reached on March 31, 2023.
Performance
MYGN Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$61.50 M
+$1.50 M+2.50%
September 1, 2024
Summary
- As of February 7, 2025, MYGN TTM depreciation & amortization is $61.50 million, with the most recent change of +$1.50 million (+2.50%) on September 1, 2024.
- Over the past year, MYGN TTM D&A has increased by +$3.30 million (+5.67%).
- MYGN TTM D&A is now -15.87% below its all-time high of $73.10 million, reached on December 31, 2019.
Performance
MYGN TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
MYGN Depreciation And Amortization Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +17.5% | -0.6% | +5.7% |
3 y3 years | +72.9% | +13.9% | +16.7% |
5 y5 years | -15.2% | -14.3% | -15.9% |
MYGN Depreciation And Amortization Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -1.4% | +17.5% | -19.6% | +20.9% | -2.1% | +17.6% |
5 y | 5-year | -15.2% | +72.9% | -19.6% | +20.9% | -15.9% | +24.2% |
alltime | all time | -15.2% | +3768.8% | -19.6% | +543.9% | -15.9% | >+9999.0% |
Myriad Genetics Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $15.60 M(+3.3%) | $61.50 M(+2.5%) |
Jun 2024 | - | $15.10 M(-3.8%) | $60.00 M(+3.1%) |
Mar 2024 | - | $15.70 M(+4.0%) | $58.20 M(-6.0%) |
Dec 2023 | $61.90 M(+17.5%) | $15.10 M(+7.1%) | $61.90 M(+2.3%) |
Sep 2023 | - | $14.10 M(+6.0%) | $60.50 M(+1.7%) |
Jun 2023 | - | $13.30 M(-31.4%) | $59.50 M(+0.7%) |
Mar 2023 | - | $19.40 M(+41.6%) | $59.10 M(+12.1%) |
Dec 2022 | $52.70 M(-16.1%) | $13.70 M(+4.6%) | $52.70 M(+0.8%) |
Sep 2022 | - | $13.10 M(+1.6%) | $52.30 M(-2.1%) |
Jun 2022 | - | $12.90 M(-0.8%) | $53.40 M(-7.0%) |
Mar 2022 | - | $13.00 M(-2.3%) | $57.40 M(-8.6%) |
Dec 2021 | $62.80 M(+75.4%) | $13.30 M(-6.3%) | $62.80 M(+26.9%) |
Sep 2021 | - | $14.20 M(-16.0%) | $49.50 M(-6.6%) |
Jun 2021 | - | $16.90 M(-8.2%) | $53.00 M(-1.5%) |
Mar 2021 | - | $18.40 M(+4.0%) | $53.80 M(-24.8%) |
Dec 2020 | $35.80 M(-50.3%) | - | - |
Sep 2020 | - | $17.70 M(0.0%) | $71.50 M(-0.7%) |
Jun 2020 | $72.00 M(-1.4%) | $17.70 M(-1.1%) | $72.00 M(-1.0%) |
Mar 2020 | - | $17.90 M(-1.6%) | $72.70 M(-0.5%) |
Dec 2019 | - | $18.20 M(0.0%) | $73.10 M(+0.3%) |
Sep 2019 | - | $18.20 M(-1.1%) | $72.90 M(-0.1%) |
Jun 2019 | $73.00 M(+34.2%) | $18.40 M(+0.5%) | $73.00 M(+4.7%) |
Mar 2019 | - | $18.30 M(+1.7%) | $69.70 M(+8.2%) |
Dec 2018 | - | $18.00 M(-1.6%) | $64.40 M(+8.2%) |
Sep 2018 | - | $18.30 M(+21.2%) | $59.50 M(+9.4%) |
Jun 2018 | $54.40 M(+12.6%) | $15.10 M(+16.2%) | $54.40 M(+3.4%) |
Mar 2018 | - | $13.00 M(-0.8%) | $52.60 M(+0.2%) |
Dec 2017 | - | $13.10 M(-0.8%) | $52.50 M(+0.4%) |
Sep 2017 | - | $13.20 M(-0.8%) | $52.30 M(+8.3%) |
Jun 2017 | $48.30 M(+80.2%) | $13.30 M(+3.1%) | $48.30 M(+15.6%) |
Mar 2017 | - | $12.90 M(0.0%) | $41.80 M(+18.1%) |
Dec 2016 | - | $12.90 M(+40.2%) | $35.40 M(+21.2%) |
Sep 2016 | - | $9.20 M(+35.3%) | $29.20 M(+9.0%) |
Jun 2016 | $26.80 M(+7.2%) | $6.80 M(+4.6%) | $26.80 M(+0.8%) |
Mar 2016 | - | $6.50 M(-3.0%) | $26.60 M(+0.4%) |
Dec 2015 | - | $6.70 M(-1.5%) | $26.50 M(+2.7%) |
Sep 2015 | - | $6.80 M(+3.0%) | $25.80 M(+3.2%) |
Jun 2015 | $25.00 M(+81.2%) | $6.60 M(+3.1%) | $25.00 M(+4.6%) |
Mar 2015 | - | $6.40 M(+6.7%) | $23.91 M(+13.9%) |
Dec 2014 | - | $6.00 M(0.0%) | $20.99 M(+20.4%) |
Sep 2014 | - | $6.00 M(+8.9%) | $17.43 M(+26.3%) |
Jun 2014 | $13.80 M(+55.1%) | $5.51 M(+58.3%) | $13.80 M(+30.7%) |
Mar 2014 | - | $3.48 M(+42.7%) | $10.56 M(+14.0%) |
Dec 2013 | - | $2.44 M(+2.8%) | $9.26 M(+2.2%) |
Sep 2013 | - | $2.37 M(+4.7%) | $9.06 M(+1.8%) |
Jun 2013 | $8.90 M(-1.9%) | $2.27 M(+3.9%) | $8.90 M(-0.7%) |
Mar 2013 | - | $2.18 M(-2.9%) | $8.96 M(-1.4%) |
Dec 2012 | - | $2.24 M(+1.5%) | $9.09 M(-0.5%) |
Sep 2012 | - | $2.21 M(-5.0%) | $9.13 M(+0.7%) |
Jun 2012 | $9.07 M(+25.6%) | $2.33 M(+1.1%) | $9.07 M(+5.2%) |
Mar 2012 | - | $2.30 M(+0.5%) | $8.62 M(+6.2%) |
Dec 2011 | - | $2.29 M(+6.7%) | $8.12 M(+6.7%) |
Sep 2011 | - | $2.15 M(+14.3%) | $7.61 M(+5.4%) |
Jun 2011 | $7.22 M(+1.9%) | $1.88 M(+4.3%) | $7.22 M(-41.9%) |
Mar 2011 | - | $1.80 M(+0.9%) | $12.43 M(+74.7%) |
Dec 2010 | - | $1.78 M(+1.5%) | $7.11 M(+0.7%) |
Sep 2010 | - | $1.76 M(-75.2%) | $7.06 M(-0.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2010 | $7.08 M(-25.0%) | $7.08 M(-301.6%) | $7.08 M(+190.4%) |
Mar 2010 | - | -$3.51 M(-302.5%) | $2.44 M(-70.8%) |
Dec 2009 | - | $1.74 M(-2.5%) | $8.36 M(-6.8%) |
Sep 2009 | - | $1.78 M(-27.1%) | $8.97 M(-5.0%) |
Jun 2009 | $9.45 M(+7.6%) | $2.44 M(+1.3%) | $9.45 M(+1.9%) |
Mar 2009 | - | $2.41 M(+2.6%) | $9.27 M(+1.3%) |
Dec 2008 | - | $2.35 M(+4.0%) | $9.15 M(+2.0%) |
Sep 2008 | - | $2.26 M(-0.1%) | $8.97 M(+2.1%) |
Jun 2008 | $8.78 M(+16.4%) | $2.26 M(-1.2%) | $8.78 M(+2.9%) |
Mar 2008 | - | $2.29 M(+5.5%) | $8.53 M(+4.0%) |
Dec 2007 | - | $2.17 M(+4.8%) | $8.20 M(+4.4%) |
Sep 2007 | - | $2.07 M(+3.0%) | $7.86 M(+4.1%) |
Jun 2007 | $7.54 M(+10.1%) | $2.01 M(+2.7%) | $7.54 M(+2.8%) |
Mar 2007 | - | $1.96 M(+7.2%) | $7.34 M(+3.4%) |
Dec 2006 | - | $1.82 M(+3.8%) | $7.10 M(+1.9%) |
Sep 2006 | - | $1.76 M(-2.6%) | $6.97 M(+1.7%) |
Jun 2006 | $6.86 M(+12.5%) | $1.80 M(+5.1%) | $6.86 M(+3.9%) |
Mar 2006 | - | $1.72 M(+1.5%) | $6.60 M(+3.0%) |
Dec 2005 | - | $1.69 M(+2.9%) | $6.40 M(+2.5%) |
Sep 2005 | - | $1.64 M(+6.3%) | $6.25 M(+2.6%) |
Jun 2005 | $6.09 M(+5.7%) | $1.55 M(+1.5%) | $6.09 M(+1.4%) |
Mar 2005 | - | $1.52 M(-0.9%) | $6.00 M(+1.2%) |
Dec 2004 | - | $1.54 M(+3.4%) | $5.93 M(+1.7%) |
Sep 2004 | - | $1.49 M(+1.9%) | $5.83 M(+1.2%) |
Jun 2004 | $5.77 M(+9.3%) | $1.46 M(+0.4%) | $5.77 M(+2.7%) |
Mar 2004 | - | $1.45 M(+1.3%) | $5.61 M(+2.9%) |
Dec 2003 | - | $1.44 M(+1.1%) | $5.45 M(+1.0%) |
Sep 2003 | - | $1.42 M(+8.7%) | $5.40 M(+2.3%) |
Jun 2003 | $5.28 M(+17.3%) | $1.31 M(+0.9%) | $5.28 M(+1.6%) |
Mar 2003 | - | $1.29 M(-6.2%) | $5.19 M(+1.7%) |
Dec 2002 | - | $1.38 M(+6.4%) | $5.10 M(+7.5%) |
Sep 2002 | - | $1.30 M(+6.2%) | $4.75 M(+5.6%) |
Jun 2002 | $4.50 M(+20.6%) | $1.22 M(+1.0%) | $4.50 M(+5.3%) |
Mar 2002 | - | $1.21 M(+17.9%) | $4.27 M(+6.2%) |
Dec 2001 | - | $1.02 M(-1.7%) | $4.02 M(+3.2%) |
Sep 2001 | - | $1.04 M(+5.0%) | $3.89 M(+4.4%) |
Jun 2001 | $3.73 M(+13.5%) | $992.60 K(+3.5%) | $3.73 M(+2.4%) |
Mar 2001 | - | $959.00 K(+6.7%) | $3.64 M(+5.2%) |
Dec 2000 | - | $898.80 K(+2.4%) | $3.46 M(+6.1%) |
Sep 2000 | - | $878.10 K(-2.9%) | $3.26 M(-0.7%) |
Jun 2000 | $3.28 M(+2.6%) | $904.70 K(+16.0%) | $3.28 M(+6.6%) |
Mar 2000 | - | $780.00 K(+11.4%) | $3.08 M(+2.7%) |
Dec 1999 | - | $700.00 K(-22.2%) | $3.00 M(-9.1%) |
Sep 1999 | - | $900.00 K(+28.6%) | $3.30 M(+3.1%) |
Jun 1999 | $3.20 M(-3.0%) | $700.00 K(0.0%) | $3.20 M(-5.9%) |
Mar 1999 | - | $700.00 K(-30.0%) | $3.40 M(-2.9%) |
Dec 1998 | - | $1.00 M(+25.0%) | $3.50 M(+6.1%) |
Sep 1998 | - | $800.00 K(-11.1%) | $3.30 M(0.0%) |
Jun 1998 | $3.30 M(+32.0%) | $900.00 K(+12.5%) | $3.30 M(+6.5%) |
Mar 1998 | - | $800.00 K(0.0%) | $3.10 M(+3.3%) |
Dec 1997 | - | $800.00 K(0.0%) | $3.00 M(+7.1%) |
Sep 1997 | - | $800.00 K(+14.3%) | $2.80 M(+12.0%) |
Jun 1997 | $2.50 M(+56.3%) | $700.00 K(0.0%) | $2.50 M(+38.9%) |
Mar 1997 | - | $700.00 K(+16.7%) | $1.80 M(+63.6%) |
Dec 1996 | - | $600.00 K(+20.0%) | $1.10 M(+120.0%) |
Sep 1996 | - | $500.00 K | $500.00 K |
Jun 1996 | $1.60 M | - | - |
FAQ
- What is Myriad Genetics annual depreciation & amortization?
- What is the all time high annual D&A for Myriad Genetics?
- What is Myriad Genetics annual D&A year-on-year change?
- What is Myriad Genetics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Myriad Genetics?
- What is Myriad Genetics quarterly D&A year-on-year change?
- What is Myriad Genetics TTM depreciation & amortization?
- What is the all time high TTM D&A for Myriad Genetics?
- What is Myriad Genetics TTM D&A year-on-year change?
What is Myriad Genetics annual depreciation & amortization?
The current annual D&A of MYGN is $61.90 M
What is the all time high annual D&A for Myriad Genetics?
Myriad Genetics all-time high annual depreciation & amortization is $73.00 M
What is Myriad Genetics annual D&A year-on-year change?
Over the past year, MYGN annual depreciation & amortization has changed by +$9.20 M (+17.46%)
What is Myriad Genetics quarterly depreciation & amortization?
The current quarterly D&A of MYGN is $15.60 M
What is the all time high quarterly D&A for Myriad Genetics?
Myriad Genetics all-time high quarterly depreciation & amortization is $19.40 M
What is Myriad Genetics quarterly D&A year-on-year change?
Over the past year, MYGN quarterly depreciation & amortization has changed by -$100.00 K (-0.64%)
What is Myriad Genetics TTM depreciation & amortization?
The current TTM D&A of MYGN is $61.50 M
What is the all time high TTM D&A for Myriad Genetics?
Myriad Genetics all-time high TTM depreciation & amortization is $73.10 M
What is Myriad Genetics TTM D&A year-on-year change?
Over the past year, MYGN TTM depreciation & amortization has changed by +$3.30 M (+5.67%)